Table 1.
Patient characteristics
| n (total = 117) | |
|---|---|
| Median age, years (range) | 75 (70–95) |
| Gender (% male) | 57 |
| Comorbidities (%) | |
| Renal disease | |
| CrCl < 30 mL/min | 23 (19) |
| CrCl between 30 and 60 mL/min | 55 (44) |
| Cardiac disease | 43 (36) |
| CAD | 12 (10) |
| CHF | 25 (21) |
| Arrhythmia | 22 (19) |
| Pulmonary disease | 6 (5) |
| Myeloma isotype (%) | |
| IgG | 56 (48) |
| IgA | 25 (21) |
| IgM | 1 (1) |
| Light chain | 28 (24) |
| Unknown | 7 (6) |
| Durie‐Salmon stage (%) | |
| I | 16 (14) |
| II | 37 (32) |
| III | 40 (34) |
| Unknown | 24 (21) |
| ISS stage (%) | |
| I | 32 (27) |
| II | 24 (21) |
| III | 32 (27) |
| Unknown | 29 (25) |
| Cytogenetics/FISH (%) | |
| High risk | 6 (5) |
| Intermediate risk | 13 (11) |
| Standard risk | 49 (42) |
| Unknown | 49 (42) |